S

Active Director Additional Director DIN 09822902
DIN 09822902 First appointment Dec 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Shashi

Data last updated:

Shashi is an Additional Director at Ishi Medipharma Private Limited (since 2022). The company operates in Trading. Ishi Medipharma Private Limited reported revenue of ₹19.4 Lakh (FY 2025).

DIN 09822902
Primary Designation Additional Director
Industry Trading
First Appointment 12 Dec 2022
Oldest Company Age 13 yrs
Largest company Ishi Medipharma Private Limited · ₹19.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ishi Medipharma Private Limited U85191UP2013PTC057396
Additional Director12 Dec 20222013₹19.4 Lakh (FY 2025)Active

Board colleagues of Shashi

NameDINCompanyDesignation
Deepak Chaturvedi06589396Ishi Medipharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ishi Medipharma Private Limited
Premium access

Shareholding and investment profile for Shashi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi

Shashi currently holds 1 directorship: Ishi Medipharma Private Limited (Additional Director, since 12 Dec 2022, revenue ₹19.4 Lakh (FY 2025)).

Shashi was first appointed on 12 Dec 2022 as Additional Director at Ishi Medipharma Private Limited.

The current boards of Shashi's companies include Deepak Chaturvedi (Ishi Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available